GB0310992D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0310992D0
GB0310992D0 GBGB0310992.3A GB0310992A GB0310992D0 GB 0310992 D0 GB0310992 D0 GB 0310992D0 GB 0310992 A GB0310992 A GB 0310992A GB 0310992 D0 GB0310992 D0 GB 0310992D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0310992.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidelta doo
Original Assignee
Glaxo Group Ltd
Pliva Farmaceutika dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Farmaceutika dd filed Critical Glaxo Group Ltd
Priority to GBGB0310992.3A priority Critical patent/GB0310992D0/en
Publication of GB0310992D0 publication Critical patent/GB0310992D0/en
Priority to DE602004010110T priority patent/DE602004010110T2/de
Priority to EP04732099A priority patent/EP1633765B1/en
Priority to ES04732099T priority patent/ES2295865T3/es
Priority to CA002525459A priority patent/CA2525459A1/en
Priority to JP2006529797A priority patent/JP2006528668A/ja
Priority to PCT/EP2004/005086 priority patent/WO2004101590A1/en
Priority to US10/556,709 priority patent/US20080221158A1/en
Priority to CNA200480019644XA priority patent/CN1820016A/zh
Priority to ARP040101615A priority patent/AR044310A1/es
Priority to AT04732099T priority patent/ATE378347T1/de
Priority to CL200401005A priority patent/CL2004001005A1/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GBGB0310992.3A 2003-05-13 2003-05-13 Novel compounds Ceased GB0310992D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB0310992.3A GB0310992D0 (en) 2003-05-13 2003-05-13 Novel compounds
CL200401005A CL2004001005A1 (es) 2003-05-13 2004-05-11 Compuestos derivados de macrolidos de 15 miembros, sustituidos en posicion 4", procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topicas.
CA002525459A CA2525459A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds
EP04732099A EP1633765B1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds
ES04732099T ES2295865T3 (es) 2003-05-13 2004-05-11 Compuestos de anillo de 14 y 15 miembros novedosos.
DE602004010110T DE602004010110T2 (de) 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen
JP2006529797A JP2006528668A (ja) 2003-05-13 2004-05-11 新規１４−及び１５−員環マクロライド
PCT/EP2004/005086 WO2004101590A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds
US10/556,709 US20080221158A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 Membered Ring Compounds
CNA200480019644XA CN1820016A (zh) 2003-05-13 2004-05-11 新型14和15元环化合物
ARP040101615A AR044310A1 (es) 2003-05-13 2004-05-11 Compuesto de macrolido de 15 miembros sustituido en la posicion 4", procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende
AT04732099T ATE378347T1 (de) 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310992.3A GB0310992D0 (en) 2003-05-13 2003-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
GB0310992D0 true GB0310992D0 (en) 2003-06-18

Family

ID=9957987

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0310992.3A Ceased GB0310992D0 (en) 2003-05-13 2003-05-13 Novel compounds

Country Status (12)

Country Link
US (1) US20080221158A1 (https=)
EP (1) EP1633765B1 (https=)
JP (1) JP2006528668A (https=)
CN (1) CN1820016A (https=)
AR (1) AR044310A1 (https=)
AT (1) ATE378347T1 (https=)
CA (1) CA2525459A1 (https=)
CL (1) CL2004001005A1 (https=)
DE (1) DE602004010110T2 (https=)
ES (1) ES2295865T3 (https=)
GB (1) GB0310992D0 (https=)
WO (1) WO2004101590A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540504A (ja) * 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用な４’’アミノ結合マクロライド
GB201706299D0 (en) * 2017-04-20 2017-06-07 Novintum Biotechnology Gmbh Compounds
WO2018193126A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as antibacterial agents
WO2021195126A1 (en) 2020-03-24 2021-09-30 Burnet Michael W Anti-infective and anti-viral compounds and compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
AU710532B2 (en) * 1996-05-07 1999-09-23 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
DE602004010110T2 (de) 2008-09-11
EP1633765B1 (en) 2007-11-14
ES2295865T3 (es) 2008-04-16
ATE378347T1 (de) 2007-11-15
CA2525459A1 (en) 2004-11-25
US20080221158A1 (en) 2008-09-11
DE602004010110D1 (de) 2007-12-27
EP1633765A1 (en) 2006-03-15
AR044310A1 (es) 2005-09-07
JP2006528668A (ja) 2006-12-21
CL2004001005A1 (es) 2005-03-18
CN1820016A (zh) 2006-08-16
WO2004101590A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308186D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
GB0308333D0 (en) Novel compounds
EP1596860A4 (en) NEW CONNECTIONS
EP1648885A4 (en) NEW CONNECTIONS
GB0305426D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
GB0310992D0 (en) Novel compounds
GB0301589D0 (en) Novel compounds
GB0306212D0 (en) Novel compounds
GB0300482D0 (en) Novel compounds
GB0300484D0 (en) Novel compounds
GB0308187D0 (en) Novel compounds
GB0300481D0 (en) Novel compounds
GB0301480D0 (en) Novel compounds
GB0305564D0 (en) Novel compounds
GB0301591D0 (en) Novel compounds
GB0301592D0 (en) Novel compounds
GB0301593D0 (en) Novel compounds
GB0301608D0 (en) Novel compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: PLIVA-ISTRAZIVACKI INSTITUT D.O.O.

Free format text: FORMER APPLICANT(S): PLIVA D.D.

AT Applications terminated before publication under section 16(1)